N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1

References

• Serke M, Schönfeld N. Diagnosis and staging of lung cancer. Dtsch Med Wochenschr. 2007;132(21):1165–1169.
   PubMed Web of Science ®Google Scholar
• Spiro SG, Tanner NT, Silvestri GA, et al. Lung cancer: progress in diagnosis, staging and therapy. Respirology. 2010;15(1):44–50
   PubMed Web of Science ®Google Scholar
• Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev. 2005;14:243–250.
   PubMed Web of Science ®Google Scholar
• Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458:223–227.
   PubMed Web of Science ®Google Scholar
• Moran VA, Perera RJ, Khalil AM. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012;40:6391–6400.
   PubMed Web of Science ®Google Scholar
• Necsulea A, Soumillon M, Warnefors M, et al. The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature. 2014;505:635–640.
   PubMed Web of Science ®Google Scholar
• Akdm R, Rajkumar T, Mani S. Perspectives of long non-coding RNAs in cancer. Mol Biol Rep. 2017;44:203–218.
   PubMed Web of Science ®Google Scholar
• Toden S, Zumwalt TJ, Goel A. Non-coding RNAs and potential therapeutic targeting in cancer. Biochimica et biophysica acta. Rev Cancer. 2021;1875:188491.
   Google Scholar
• Chandra GS, Nandan TY. Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets. Int J Cancer. 2017;140:1955–1967.
   PubMed Web of Science ®Google Scholar
• Chi Y, Wang D, Wang J, et al. Long non-coding RNA in the pathogenesis of cancers. Cells. 2019;8(9):1015.
   Web of Science ®Google Scholar
• Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861–874.
   PubMed Web of Science ®Google Scholar
• Acha-Sagredo A, Uko B, Pantazi P, et al. Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis. Br J Cancer. 2020;122(7):1050–1058.
   PubMed Web of Science ®Google Scholar
• Ma Z, Ji J. N6-methyladenosine (m6A)RNA modification in cancer stem cells. Stem Cells. 2020;38(12):1511–1519.
   Web of Science ®Google Scholar
• Widagdo J, Anggono V. The m6A-epitranscriptomic signature in neurobiology: from neurodevelopment to brain plasticity. J Neurochem. 2018;147(2):137–152.
   PubMed Web of Science ®Google Scholar
• Zhang H, Shi X, Huang T, et al. Dynamic landscape and evolution of m6A methylation in human. Nucleic Acids Res. 2020;48(11):6251–6264.
   PubMed Web of Science ®Google Scholar
• Huang H, Weng H, Chen J. m6A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37:270–288.
   PubMed Web of Science ®Google Scholar
• Liu ZX, Li LM, Sun HL, et al. Link between m6A modification and cancers. Front Bioeng Biotechnol. 2018;6:89.
   PubMed Web of Science ®Google Scholar
• Liu P, Zhang B, Chen Z, et al. m6A-induced lncRNA MALAT1 aggravates renal fibrogenesis in obstructive nephropathy through the miR-145/FAK pathway. Aging (Albany NY). 2020;12(6):5280–5299.
   PubMedGoogle Scholar
• Yang C, Fan Z, Yang J. m6A modification of LncRNA MALAT1: a novel therapeutic target for myocardial ischemia-reperfusion injury. Int J Cardiol. 2020;306:162.
   PubMed Web of Science ®Google Scholar
• Xue L, Li J, Lin Y, et al. m6A transferase METTL3-induced lncRNA ABHD11-AS1 promotes the Warburg effect of non-small-cell lung cancer. J Cell Physiol. 2021;236(4):2649–2658.
   PubMed Web of Science ®Google Scholar
• Allmann S, Mayer L, Olma J, et al. Benzo[a]pyrene represses DNA repair through altered E2F1/E2F4 function marking an early event in DNA damage-induced cellular senescence. Nucleic Acids Res. 2020;48(21):12085–12101.
   PubMed Web of Science ®Google Scholar
• Denechaud PD, Fajas L, Giralt A. E2F1, a novel regulator of metabolism. Front Endocrinol (Lausanne). 2017;8:311.
   PubMed Web of Science ®Google Scholar
• Ertosun MG, Hapil FZ, Osman Nidai O. E2F1 transcription factor and its impact on growth factor and cytokine signaling. Cytokine Growth Factor Rev. 2016;31:17–25.
   PubMed Web of Science ®Google Scholar
• Singh S, Yennamalli RM, Gupta M, et al. Identification of nsSNPs of transcription factor E2F1 predisposing individuals to lung cancer and head and neck cancer. Mutat Res. 2020;821:111704.
   PubMed Web of Science ®Google Scholar
• Dimitrov D, Konstantinov D. Choice of x-ray diagnostic methods in chronic odontogenic sinusitis. Radiologia diagnostica. 1989;30:67–71.
   PubMedGoogle Scholar
• Fang Z, Lin M, Li C, et al. A comprehensive review of the roles of E2F1 in colon cancer. Am J Cancer Res. 2020;10:757–768.
   PubMed Web of Science ®Google Scholar
• Feng DD, Cao Q, Zhang DQ, et al. Transcription factor E2F1 positively regulates interferon regulatory factor 5 expression in non-small cell lung cancer. Onco Targets Ther. 2019;12:6907–6915.
   PubMed Web of Science ®Google Scholar
• Zheng X, Huang M, Xing L, et al. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer. 2020;19:73.
   PubMed Web of Science ®Google Scholar
• Zhi T, Jiang K, Xu X, et al. ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1. Neuro Oncol. 2019;21:462–473.
   PubMed Web of Science ®Google Scholar
• Győrffy B, Surowiak P, Budczies J, et al. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One. 2013;8(12):e82241.
   PubMed Web of Science ®Google Scholar
• Liu J, Lichtenberg T, Hoadley KA, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400–416.e11.
   PubMed Web of Science ®Google Scholar
• Tang Z, Kang B, Li C, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–W560.
   PubMed Web of Science ®Google Scholar
• Peng Z, Wang J, Shan B, et al. Genome-wide analyses of long noncoding RNA expression profiles in lung adenocarcinoma. Sci Rep. 2017;7(1):15331.
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Dominissini D, Moshitch-Moshkovitz S, Salmon-Divon M, et al. Transcriptome-wide mapping of N(6)-methyladenosine by m(6)A-seq based on immunocapturing and massively parallel sequencing. Nat Protoc. 2013;8(1):176–189.
   PubMed Web of Science ®Google Scholar
• Chen CY, Ezzeddine N, Shyu AB. Messenger RNA half-life measurements in mammalian cells. Methods Enzymol. 2008;448:335–357.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zeng P, Li YH, et al. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44(10):e91.
   PubMed Web of Science ®Google Scholar
• Jingushi K, Aoki M, Ueda K, et al. ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer. Sci Rep. 2021;11(1):8677.
   PubMed Web of Science ®Google Scholar
• Yang X, Feng M, Jiang X, et al. miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A. Genes Dev. 2009;23(20):2388–2393.
   PubMed Web of Science ®Google Scholar
• Park MT, Lee SJ. Cell cycle and cancer. J Biochem Mol Biol. 2003;36(1):60–65.
   PubMedGoogle Scholar
• Wang F, Zhang L. p15(INK4b) regulates cell cycle signaling in hippocampal astrocytes of aged rats. Aging Clin Exp Res. 2016;28(5):813–821.
   PubMed Web of Science ®Google Scholar
• Velásquez ZD, López-Osorio S, Waiger D, et al. Eimeria bovis infections induce G(1) cell cycle arrest and a senescence-like phenotype in endothelial host cells. Parasitology. 2021;148(3):341–353.
   PubMed Web of Science ®Google Scholar
• Archer K, Broskova Z, Bayoumi AS, et al. Long non-coding RNAs as master regulators in cardiovascular diseases. Int J Mol Sci. 2015;16(10):23651–23667.
   PubMed Web of Science ®Google Scholar
• Ravnskjaer K. Keystone symposia on epigenomics and chromatin dynamics: keystone resort, CO, January 17-22, 2012. Epigenetics. 2012;7(5):522–523.
   PubMedGoogle Scholar
• Chan JJ, Tay Y. Noncoding RNA:RNA regulatory networks in cancer. Int J Mol Sci. 2018;19(5):1310.
   PubMed Web of Science ®Google Scholar
• Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genomics Proteomics Bioinformatics. 2016;14:42–54.
   PubMed Web of Science ®Google Scholar
• Castro-Oropeza R, Melendez-Zajgla J, Maldonado V, et al. The emerging role of lncRNAs in the regulation of cancer stem cells. Cell Oncol (Dordr). 2018;41:585–603.
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253–1261.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lu JH, Wu QN, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Mol Cancer. 2019;18:174.
   PubMed Web of Science ®Google Scholar
• Li H, Tong F, Meng R, et al. E2F1-mediated repression of WNT5A expression promotes brain metastasis dependent on the ERK1/2 pathway in EGFR-mutant non-small cell lung cancer. Cell Mol Life Sci. 2021;78(6):2877–2891.
   PubMed Web of Science ®Google Scholar
• Meng Q, Liu M, Cheng R. LINC00461/miR-4478/E2F1 feedback loop promotes non-small cell lung cancer cell proliferation and migration. Biosci Rep. 2020;40(2). DOI:10.1042/BSR20191345
   Google Scholar
• Shi J, Li J, Yang S, et al. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway. J Cell Physiol. 2020;235(3):2891–2900.
   PubMed Web of Science ®Google Scholar
• Li X, Yang S, Zhang M, et al. Downregulation of SRPK2 promotes cell cycle arrest though E2F1 in non-small cell lung cancer. Eur J Histochem. 2019;63(4). DOI:10.4081/ejh.2019.3067
   Web of Science ®Google Scholar